Candida infections in non-neutropenic children after the neonatal period

References

• Fridkin SK. The changing face of fungal infections in health care settings. Clin. Infect. Dis.41, 1455–1460 (2005).
   PubMed Web of Science ®Google Scholar
• Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidemia in children: results of a 9-year study. Mycoses51, 248–257 (2008).
   PubMed Web of Science ®Google Scholar
• Edwards JE. Candida species. In: Principles and Practice of Infectious Disease (7th Edition). Mandell GL, Douglas RG, Bennett JE (Eds). Churchill Livingstone, NY, USA, 2289–2306 (2010).
   Google Scholar
• Knapp KM, Flynn PM. Candidiasis. In: Textbook of Pediatric Infectious Disease (6th Edition). Feigin RD, Cherry JD, Demler-Harrison GJ, Kaplan SL (Eds). Saunders, PA, USA, 2741–2751 (2009).
   Google Scholar
• Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J. Clin. Microbiol.47, 2392–2397 (2009).
   PubMed Web of Science ®Google Scholar
• Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev.21, 606–625 (2008).
   PubMed Web of Science ®Google Scholar
• Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis.3, 685–702 (2003).
   PubMed Web of Science ®Google Scholar
• Conde-Rosa A, Amador R, Pérez-Torres D et al. Candidemia distribution, associated risk factors, and attributed mortality at a university-based medical center. PR Health Sci. J.29, 26–29 (2010).
   PubMed Web of Science ®Google Scholar
• Filioti J, Spiroglou K, Panteliadis CP, Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med.33, 1272–1283, (2007).
   PubMed Web of Science ®Google Scholar
• Blyth CC, Chen SC, Slavin MA et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics123, 1360–1368 (2009).
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu J et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis.41, 1232–1239 (2005).
   PubMed Web of Science ®Google Scholar
• El-Nawawy AA, Abd El-Fattah MM, Metwally HA, Barakar SS, Hasan IA. One year study of bacterial and fungal nosocomial infections among patients in pediatric intensive care unit (PICU) in Alexandria. J. Trop. Pediatr.52, 185–191 (2006).
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Rodriguez D, Almirante B et al.In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population based active surveillance programme, Barcelona, Spain, 2002–2003. J. Antimicrob. Chemother.55, 194–199 (2005).
   PubMed Web of Science ®Google Scholar
• Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics116, 61–67 (2005).
   PubMed Web of Science ®Google Scholar
• Neu N, Malik M, Lunding A et al. Epidemiology of candidemia at a children’s hospital, 2002 to 2006. Pediatr. Infect. Dis. J.28, 806–809 (2009).
   PubMed Web of Science ®Google Scholar
• San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect. Control. Hosp. Epidemiol.26, 548–552 (2005).
   PubMedGoogle Scholar
• Zaoutis TE, Coffin SE, Chu JH et al. Risk factors for mortality in children with candidemia. Pediatr. Infect. Dis. J.24, 736–739 (2005).
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Prasad PA, Localio AR et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin. Infect. Dis.51, 38–45 (2010).
   PubMed Web of Science ®Google Scholar
• San Miguel LG, Cobo J, Otheo E et al. Candidemia in pediatric patients with congenital heart disease. Diagn. Microbiol. Infect. Dis.55, 203–207 (2006).
   PubMedGoogle Scholar
• Zaoutis T. Candidemia in children. Curr. Med. Res. Opin.26, 1761–1768 (2010).
   PubMed Web of Science ®Google Scholar
• Marodi L, Johnston RB Jr. Invasive Candida species disease in infants and children: occurrence, risk factors, management, and innate host defense mechanisms. Curr. Opin. Pediatr.19, 693–697 (2007).
   PubMed Web of Science ®Google Scholar
• Charles PE, Dalle F, Aube H et al.Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med.31, 393–400 (2005).
   PubMed Web of Science ®Google Scholar
• Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr. Crit. Care Med.9, 91–95 (2008).
   PubMed Web of Science ®Google Scholar
• Zaoutis T, Prasad P, Localio RA et al. Risk factors for candidemia in the pediatric intensive care unit. Abstracts of the Society for Healthcare Epidemiology of America Annual Meeting, San Diego, CA, USA, 19–22 March 2009 (Abstract 503).
   Google Scholar
• Almuneef MA, Memish ZA, Balkhy HH, Hijazi O, Cunningham G, Francis C. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia. J. Hosp. Infect.62, 207–213 (2006).
   PubMed Web of Science ®Google Scholar
• Phaller MA, Diekman DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev.20, 133–163 (2007).
   PubMedGoogle Scholar
• Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin. Infect. Dis.20, 571–575 (1995).
   PubMed Web of Science ®Google Scholar
• Pappas PG, Rex JH, Lee J et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis.37, 634–643 (2003).
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr. Infect. Dis. J.23, 635–664 (2004).
   PubMed Web of Science ®Google Scholar
• Weinberger M, Leibovici L, Perez S et al. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J. Hosp. Infect.61, 146–154 (2005).
   PubMedGoogle Scholar
• Paganini H, Brieshcke TR, Santos P, Seu S, Rosanova MT. Risk factors for nosocomial candidemia: a case–control study in children. J. Hosp. Infect.50, 304–308 (2002).
   PubMedGoogle Scholar
• Naglik JR, Rodgers CA, Shirlaw PJ et al. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis.188, 469–479 (2003).
   PubMed Web of Science ®Google Scholar
• Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun.75, 2126–2135 (2007).
   PubMed Web of Science ®Google Scholar
• Samonis G, Gikas A, Toloudis P et al. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis.13, 665–667 (1994).
   PubMed Web of Science ®Google Scholar
• Bendel CM, Wiesner SM, Garni RM et al. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone. Pediatr. Res.51, 290–295 (2002).
   PubMed Web of Science ®Google Scholar
• Chapman RL, Faix RG. Invasive neonatal candidiasis: an overview. Semin. Perinatol.27, 352–356 (2003).
   PubMedGoogle Scholar
• Bernhardt H. Candida in the ecological system of the orointestinal tract. Mycoses39(Suppl. 1), 44–47 (1996).
   PubMedGoogle Scholar
• Knoke M. Gastrointestinal microecology of humans and Candida. Mycoses42(Suppl. 1), 30–34 (1999).
   PubMedGoogle Scholar
• Bernhardt H, Knoke M. Mycological aspects of gastrointestinal microflora. Scand. J. Gastroenterol. (Suppl. 222), 102–106 (1997).
   Google Scholar
• Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol.6, 915–926 (2004).
   PubMed Web of Science ®Google Scholar
• Falgier C, Kegley S, Podgorski H et al.Candida species differ in their interactions with immature human gastrointestinal epithelial cells. Pediatr. Res.69, 384–389 (2011).
   PubMedGoogle Scholar
• Deng Z, Kiyuna A, Hasegawa M, Nakasone I, Hosokawa A, Suzuki M. Oral candidiasis in patients receiving radiation therapy for head and neck cancer. Otolaryngol. Head Neck Surg.143, 242–247 (2010).
   PubMedGoogle Scholar
• Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy61, 518–526 (2006).
   PubMed Web of Science ®Google Scholar
• Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. Cochrane Database Syst. Rev.19, CD003940 (2006).
   Google Scholar
• Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med.322, 1829–1836 (1990).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr. Infect. Dis. J.20, 197–206 (2001).
   PubMed Web of Science ®Google Scholar
• Mimidis K, Papadopoulos V, Margaritis V et al. Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: are they always present? Int. J. Clin. Pract.59, 210–213 (2005).
   PubMed Web of Science ®Google Scholar
• Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis – an adverse effect of inhaled corticosteroids therapy. J. Asthma46, 399–401 (2009).
   PubMed Web of Science ®Google Scholar
• Aun MV, Ribeiro MR, Garcia CLC, Agondi RC, KalilmJ, Giavina-Bianchi P. Esophageal candidiasis – an adverse effect of inhaled corticosteroids therapy. J. Asthma46, 399–401 (2009).
   PubMed Web of Science ®Google Scholar
• Salman AG, Mansour DE, Radwan AA, Mansour LE. Polymerase chain reaction in pediatric post-traumatic fungal endophthalmitis among Egyptian children. Ocul. Immunol. Inflamm.18, 127–132 (2010).
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis.48, 503–535 (2009).
   PubMed Web of Science ®Google Scholar
• Perez Blazquez E. Ophtalmoscopic examination in critically ill non-neutropenic patients: Candida endophtalmitis. Rev. Iberoam. Micol.23, 16–19 (2006).
   PubMedGoogle Scholar
• Pasqualotto AC. Candida and the paediatric lung. Paediatr. Resp. Rev.10, 186–191 (2009).
   PubMedGoogle Scholar
• Meersseman W, Lagrou K, Spriet I et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med.35, 1526–1531 (2009).
   PubMed Web of Science ®Google Scholar
• Wood GC, Mueller EW, Croce MA et al.Candida spp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients. Intensive Care Med.32, 599–603 (2006).
   PubMedGoogle Scholar
• Montravers P, Dupont H, Cauzit R et al.Candida as a risk factor for mortality in peritonitis. Crit. Care Med.34, 646–652 (2006).
   PubMed Web of Science ®Google Scholar
• Unal A, Kocyigit I, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Fungal peritonitis in peritoneal dialysis: an analysis of 21 cases. Int. Urol. Nephrol.43, 211–213 (2011).
   PubMedGoogle Scholar
• Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit. Dial. Int.29, 161–165 (2009).
   PubMedGoogle Scholar
• Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int.58, 384–389 (2000).
   PubMedGoogle Scholar
• Raaijmakers R, Schröder C, Monnens L, Cornelissen E, Warris A. Fungal peritonitis in children on peritoneal dialysis. Pediatr. Nephrol.22, 288–293 (2007).
   PubMedGoogle Scholar
• Kauffman CA. Candiduria. Clin. Infect. Dis.41, S371–S376 (2005).
   PubMed Web of Science ®Google Scholar
• Chen SC, Tong ZS, Lee OC et al. Clinician response to Candida organisms in the urine of patients attending hospital. Eur. J. Clin. Microbiol. Infect. Dis.27, 201–208 (2008).
   PubMed Web of Science ®Google Scholar
• Carvalho M, Guimaraes CM, Mayer JR Jr, Bordignon GP, Queiroz-Telles F. Hospital associated funguria: analysis of risk factors, clinical presentation and outcome. Braz. J. Infect. Dis.5, 313–318. (2001).
   PubMedGoogle Scholar
• Binelli CA, Moretti ML, Assis RS et al. Investigation of the possible association between nosocomial candiduria and candidemia. Clin. Microbiol. Infect.12, 538–543 (2006).
   PubMedGoogle Scholar
• Kale H, Narlawar RS, Rathod K. Renal fungal ball: an unusual sonographic finding. J. Clin. Ultrasound30, 178–180 (2002).
   PubMedGoogle Scholar
• Millar BC, Jugo J, Moore JE. Fungal endocarditis in neonates and children. Pediatr. Cardiol.26, 517–536 (2005).
   PubMedGoogle Scholar
• Falcone M, Barzaghi N, Carosi G et al.Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore)88, 160–168 (2009).
   PubMed Web of Science ®Google Scholar
• Rabinovici R, Szewczyk D, Ovadia P et al.Candida pericarditis: clinical profile and treatment. Ann. Thorac. Surg.63, 1200–1204 (1997).
   PubMedGoogle Scholar
• Neughebauer B, AlvarezV, Harb T, Keefer M. Constrictive pericarditis caused by Candida glabrata in an immunocompetent patient: case report and review of literature. Scand. J. Infect. Dis.34, 615–619 (2002).
   PubMed Web of Science ®Google Scholar
• Dato VM, Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr. Infect. Dis. J.9, 309–314 (1990).
   PubMed Web of Science ®Google Scholar
• Hacimustafaoglu M, Ener B, Tarim O, Kilic S, Tanritanir A, Ildirim I. Systemic candidiasis with acute Epstein–Barr virus infection. Acta Paediatr.86, 1267–1270 (1997).
   PubMedGoogle Scholar
• Hacimustafaoglu M, Cil E, Sarisözen B, Zincirci M, Ildirim I. Bilateral septic arthritis of the knee joint in three children caused by unusual infectious agents. Pediatr. Int.43, 697–700 (2001).
   PubMedGoogle Scholar
• Swanson J, Hughes PA, Messer SA et al.Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant. J. Pediatr.129, 688–694 (1996).
   PubMed Web of Science ®Google Scholar
• Miller DJ, Mejicano GC. Vertebral osteomyelitis: due to Candida species: case report and literature review. Clin. Infect. Dis.33, 523–530 (2001).
   PubMed Web of Science ®Google Scholar
• Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn. Microbiol. Infect. Dis.37, 169–179 (2000).
   PubMed Web of Science ®Google Scholar
• Verweij PE, van der Lee HAL, Rijs AJM. The role of conventional diagnostic tools. In: Diagnosis of Fungal Infections. Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 19–39 (2007).
   Google Scholar
• Meyer MH, Letscher-Bru V, Jaulhac B, Waller J, Candolfi E. Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the Bactec 9240 system. J. Clin. Microbiol.42, 773–777 (2004).
   PubMed Web of Science ®Google Scholar
• Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn. Microbiol. Infect. Dis.34, 213–220 (1999).
   PubMedGoogle Scholar
• Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg.220, 751–758 (1994).
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L. Invasive yeast infections. In: Diagnosis of Fungal Infections. Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 221–238 (2007).
   Google Scholar
• Morrison CJ, Warnock DW. Serodiagnosis: antibody and antigen detection. In: Diagnosis of Fungal Infections. Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 65–119 (2007).
   Google Scholar
• Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev.15, 465–484 (2002).
   PubMed Web of Science ®Google Scholar
• Prella M, Bille J, Pugnale M et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn. Microbiol. Infect. Dis.51, 95–101 (2005).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Merz WG, Lee JW et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am. J. Med.99, 164–172 (1995).
   PubMedGoogle Scholar
• Odabasi Z, Mattiuzzi G, Estey E et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis.39, 199–205 (2004).
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1–3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis.41, 654–659 (2005).
   PubMed Web of Science ®Google Scholar
• Sendid B, Poirot JL, Tabouret M et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol.51, 433–442 (2002).
   PubMed Web of Science ®Google Scholar
• Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther.7(10), 1201–1221 (2009).
   PubMed Web of Science ®Google Scholar
• Landlinger C, Preuner S, Bašková L et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia24, 2032–2038 (2010).
   PubMed Web of Science ®Google Scholar
• Lamoth F, Jaton K, Prod’hom G et al. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J. Clin. Microbiol.48, 3510–3516 (2010).
   PubMed Web of Science ®Google Scholar
• McMullan R, Metwally L, Coyle PV et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in non-neutropenic, critically ill adults. Clin. Infect. Dis.46, 890–896 (2008).
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A et al. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl.13, 1011–1016 (2007).
   PubMed Web of Science ®Google Scholar
• Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidasis: systematic review and meta-analysis. J. Clin. Microbiol.49, 665–670 (2011).
   PubMed Web of Science ®Google Scholar
• Lee BE, Cheung PY, Robinson JL et al. Comparative study of mortality and morbidity in premature infants (birth weight <1,250 g) with candidemia or Candida meningitis. Clin. Infect. Dis.27, 559–565 (1998).
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Yu VL. Meningitis caused by Candida species: an emerging problem in neurosurgical patients. Clin. Infect. Dis.21, 323–327 (1995).
   PubMed Web of Science ®Google Scholar
• Celebi S, Hacimustafaoglu M, Calişkan S, Ildirim I. Cases with Candida meningitis. Presented at: National Pediatric Infectious Diseases Congress, Adana, Turkey, 26–29 October 2001.
   Google Scholar
• Greene R. The role of radiology in the diagnosis of fungal infections. In: Diagnosis of Fungal Infections. Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 41–63 (2007).
   Google Scholar
• Pappas PG, Bergamo B. Superficial and mucosal fungal infections. In: Diagnosis of Fungal Infections. Maertens JA, Marr KA (Eds). Informa Healthcare, NY, USA, 153–169 (2007).
   Google Scholar
• Vazquez JA, Sobel JD. Candidiasis. In: Clinical Mycology. Dismukes WE, Pappas PG, Sobel JD (Eds). Oxford University Press, NY, USA, 143–187 (2003).
   Google Scholar
• Sobel JD, Faro S, Force RW et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol.178, 203–211 (1998).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Candidiasis (moniliasis, thrush). In: Red Book: 2009 Report of the Committee on Infectious Diseases (28th Edition). Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds). American Academy of Pediatrics, IL, USA, 245–249 (2009).
   Google Scholar
• Pfaller MA, Diekema DJ, Ostrosky-Zeichner L et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J. Clin. Microbiol.46, 2620–2629 (2008).
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Jafri HS, Huang LM et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics123, 877–884 (2009).
   PubMed Web of Science ®Google Scholar
• Queiroz-Telles F, Berezin E, Leverger G et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr. Infect. Dis. J.27, 820–826 (2008).
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Perfect JR. Antifungal agents. In: Neonatal and Pediatric Pharmacology. Therapeutic Principles in Practice (3rd Edition). Yaffe SJ, Aranda JV (Eds). Lippincott Williams Wilkins, PA, USA, 459–475 (2005).
   Google Scholar
• Pfaller MA, Diekema DJ, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In: Antibiotics in Laboratory Medicine (5th Edition). Lorian V (Ed.). Lippincott Williams & Wilkins, PA, USA, 226–265 (2005).
   Google Scholar
• Steinbach WJ. Antifungal agents in children. Pediatr. Clin. North Am.52, 895–915 (2005).
   PubMedGoogle Scholar
• Karlsson O, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob. Agents. Chemother.53, 935–944 (2009).
   PubMed Web of Science ®Google Scholar
• Gudlaugsson O. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis.34, 1172–1177 (2003).
   Google Scholar
• Slavoski LA, Tunkel AR. Therapy of fungal meningitis. Clin. Neuropharmacol.18, 195–112 (1995).
   Google Scholar
• Groll AH, Giri N, Petraitis V et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J. Infect. Dis.182, 274–282 (2000).
   PubMed Web of Science ®Google Scholar
• Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin. Infect. Dis.37, 728–732 (2003).
   PubMed Web of Science ®Google Scholar
• Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect. Dis.5, 775–785 (2005).
   PubMed Web of Science ®Google Scholar
• Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn. Microbiol. Infect. Dis.20, 33–40 (1994).
   PubMed Web of Science ®Google Scholar